These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8377686)

  • 21. Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.
    Jivegård L; Drott C; Gelin J; Groth O; Hensäter M; Jensen N; Johansson G; Konrad P; Lindberg B; Lindhagen A; Lundqvist B; Oden A; Smith L; Stenberg B; Thornell E; Wingren U; Ortenwall P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):190-8. PubMed ID: 15649728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial versus venous bypass grafts in patients with in-stent restenosis.
    Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
    Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.
    Pantely GA; Goodnight SH; Rahimtoola SH; Harlan BJ; DeMots H; Calvin L; Rösch J
    N Engl J Med; 1979 Nov; 301(18):962-6. PubMed ID: 386118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate-term patency of saphenous vein graft with a clampless hand-sewn proximal anastomosis device after off-pump coronary bypass grafting.
    Shimokawa T; Manabe S; Sawada T; Matsuyama S; Fukui T; Takanashi S
    Ann Thorac Surg; 2009 May; 87(5):1416-20. PubMed ID: 19379877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
    Veeger NJ; Zijlstra F; Hillege HL; van der Meer J;
    Ann Thorac Surg; 2010 Nov; 90(5):1515-21. PubMed ID: 20971252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
    Goldman S; Zadina K; Moritz T; Ovitt T; Sethi G; Copeland JG; Thottapurathu L; Krasnicka B; Ellis N; Anderson RJ; Henderson W;
    J Am Coll Cardiol; 2004 Dec; 44(11):2149-56. PubMed ID: 15582312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
    Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.
    Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
    Sanz G
    Thromb Res Suppl; 1990; 12():23-6. PubMed ID: 2082484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
    J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can aortocoronary and peripheral venous bypass graft patency be improved by the administration of pentoxifylline on a long-term basis?
    Angelides NS; Minas C
    Cardiologia; 1999 Dec; 44(12):1059-64. PubMed ID: 10687256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.
    Khot UN; Friedman DT; Pettersson G; Smedira NG; Li J; Ellis SG
    Circulation; 2004 May; 109(17):2086-91. PubMed ID: 15123539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
    Collins P; Webb CM; Chong CF; Moat NE;
    Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and midterm patency of the proximal anastomoses of saphenous vein grafts made with a Symmetry Aortic Connector System.
    Kitamura H; Okabayashi H; Hanyu M; Soga Y; Nomoto T; Johno H; Nakano J; Matsuo T; Kai M; Umehara E
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1028-31. PubMed ID: 16214515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.